Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

FDA committee votes on approval of Quad regimen

May 14, 2012

FDA advisory committee issues recommendation on Truvada

May 11, 2012

Bionor Pharma reports on Vacc-4x/Endocine study

May 11, 2012

IAVI, GMI and G&D partner to develop novel AIDS vaccine

May 11, 2012

Scientists in Japan present new agents active against drug-resistant HIV-1

May 2, 2012

Scientists in Europe uncover new recognition factor for HIV-1 entry

April 27, 2012

DFH Pharma and NIH collaborate on development of HIV drugs

April 18, 2012

New potential therapies for HIV infection reported by Roche

April 13, 2012

Bristol-Myers Squibb presents novel HIV integrase inhibitors

April 10, 2012

Shionogi-ViiV Healthcare reports initial data from phase III dolutegravir trial

April 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...